石四药集团(02005.HK)：取得有关新增2ml规格的复合磷酸氢钾注射液的药品生产注册批件

Core Viewpoint - The company, Stone Four Pharmaceutical Group, has obtained a production registration approval from the National Medical Products Administration of China for a new 2ml specification of compound potassium hydrogen phosphate injection, classified as a Class 3 chemical drug and considered to have passed the consistency evaluation [1] Group 1 - The compound potassium hydrogen phosphate injection is a compound preparation used to correct hypophosphatemia in adult and pediatric patients when oral or enteral nutrition is not feasible, insufficient, or contraindicated [1] - The injection is also utilized for parenteral nutrition in both adult and pediatric patients [1]